Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.915
+0.135 (7.58%)
Oct 8, 2025, 2:51 PM EDT - Market open
Quince Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$8.00
Upside
+317.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +108.88% | Sep 26, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +108.88% | Aug 15, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +317.75% | Aug 12, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $9 | Buy | Initiates | $9 | +369.97% | Aug 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +108.88% | Jul 17, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +108.88% | Jun 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +108.88% | Jun 4, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 → $4 | Strong Buy | Maintains | $12 → $4 | +108.88% | Mar 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +422.19% | Mar 24, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +526.63% | Feb 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +526.63% | Jan 2, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +369.97% | Dec 18, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +526.63% | Nov 14, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +526.63% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +213.32% | Nov 7, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +474.41% | Oct 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.